Patent 8637086 was granted and assigned to Klox Technologies on January, 2014 by the United States Patent and Trademark Office.
There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.